Year |
Citation |
Score |
2024 |
Correa Pinto Junior D, Canal Delgado I, Yang H, Clemenceau A, Corvelo A, Narzisi G, Musunuri R, Meyer Berger J, Hendricks LE, Tokumura K, Luo N, Li H, Oury F, Ducy P, Yadav VK, et al. Osteocalcin of maternal and embryonic origins synergize to establish homeostasis in offspring. Embo Reports. PMID 38228788 DOI: 10.1038/s44319-023-00031-3 |
0.66 |
|
2023 |
Pinto DC, Delgado IC, Yang H, Clemenceau A, Corvelo A, Narzisi G, Musunuri R, Berger JM, Hendricks LE, Tokumura K, Luo N, Li H, Oury F, Ducy P, Yadav VK, et al. Osteocalcin of maternal and embryonic origins synergize to establish homeostasis in offspring. Biorxiv : the Preprint Server For Biology. PMID 37645714 DOI: 10.1101/2023.08.11.552969 |
0.658 |
|
2023 |
Ducy P. A central regulation of PTH secretion and function. Neuron. 111: 1847-1849. PMID 37348456 DOI: 10.1016/j.neuron.2023.05.018 |
0.301 |
|
2020 |
Ducy P. Bone Regulation of Insulin Secretion and Glucose Homeostasis. Endocrinology. 161. PMID 32822470 DOI: 10.1210/endocr/bqaa149 |
0.491 |
|
2018 |
Ducy PF, Karsenty G. Endocrine Bioenergetics of Bone Primer On the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 1012-1019. DOI: 10.1002/9781119266594.Ch130 |
0.612 |
|
2016 |
Liu JM, Rosen CJ, Ducy P, Kousteni S, Karsenty G. Regulation of Glucose Handling by the Skeleton: Insights From Mouse and Human Studies. Diabetes. 65: 3225-3232. PMID 27959858 DOI: 10.2337/Db16-0053 |
0.633 |
|
2016 |
Ortuño MJ, Robinson ST, Subramanyam P, Paone R, Huang YY, Guo XE, Colecraft HM, Mann JJ, Ducy P. Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect. Nature Medicine. PMID 27595322 DOI: 10.1038/Nm.4166 |
0.454 |
|
2014 |
Kode A, Obri A, Paone R, Kousteni S, Ducy P, Karsenty G. Lrp5 regulation of bone mass and serotonin synthesis in the gut. Nature Medicine. 20: 1228-9. PMID 25375916 DOI: 10.1038/Nm.3698 |
0.601 |
|
2014 |
Wei J, Hanna T, Suda N, Karsenty G, Ducy P. Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a. Diabetes. 63: 1021-31. PMID 24009262 DOI: 10.2337/Db13-0887 |
0.519 |
|
2012 |
Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML, Bruyère O, Compston J, Ducy P, Ferrari S, Harvey NC, Kanis JA, Karsenty G, Laslop A, Rabenda V, et al. Antidepressant medications and osteoporosis. Bone. 51: 606-13. PMID 22659406 DOI: 10.1016/J.Bone.2012.05.018 |
0.46 |
|
2012 |
Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 50: 568-75. PMID 21550430 DOI: 10.1016/J.Bone.2011.04.017 |
0.693 |
|
2011 |
Inose H, Zhou B, Yadav VK, Guo XE, Karsenty G, Ducy P. Efficacy of serotonin inhibition in mouse models of bone loss. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 2002-11. PMID 21608033 DOI: 10.1002/Jbmr.439 |
0.741 |
|
2011 |
Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia. 54: 1291-7. PMID 21503740 DOI: 10.1007/s00125-011-2155-z |
0.467 |
|
2011 |
Oury F, Sumara G, Sumara O, Ferron M, Chang H, Smith CE, Hermo L, Suarez S, Roth BL, Ducy P, Karsenty G. Endocrine regulation of male fertility by the skeleton. Cell. 144: 796-809. PMID 21333348 DOI: 10.1016/J.Cell.2011.02.004 |
0.799 |
|
2011 |
Ducy P. 5-HT and bone biology. Current Opinion in Pharmacology. 11: 34-8. PMID 21320797 DOI: 10.1016/j.coph.2011.01.007 |
0.443 |
|
2010 |
Ducy P, Karsenty G. The two faces of serotonin in bone biology. The Journal of Cell Biology. 191: 7-13. PMID 20921133 DOI: 10.1083/Jcb.201006123 |
0.623 |
|
2010 |
Nistala H, Lee-Arteaga S, Smaldone S, Siciliano G, Carta L, Ono RN, Sengle G, Arteaga-Solis E, Levasseur R, Ducy P, Sakai LY, Karsenty G, Ramirez F. Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation. The Journal of Cell Biology. 190: 1107-21. PMID 20855508 DOI: 10.1083/Jcb.201003089 |
0.613 |
|
2010 |
Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 142: 296-308. PMID 20655470 DOI: 10.1016/J.Cell.2010.06.003 |
0.754 |
|
2010 |
Ferron M, Wei J, Yoshizawa T, Ducy P, Karsenty G. An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochemical and Biophysical Research Communications. 397: 691-6. PMID 20570657 DOI: 10.1016/J.Bbrc.2010.06.008 |
0.701 |
|
2010 |
Wei J, Ducy P. Co-dependence of bone and energy metabolisms. Archives of Biochemistry and Biophysics. 503: 35-40. PMID 20515647 DOI: 10.1016/j.abb.2010.05.021 |
0.373 |
|
2010 |
Yadav VK, Ducy P. Lrp5 and bone formation : A serotonin-dependent pathway. Annals of the New York Academy of Sciences. 1192: 103-9. PMID 20392224 DOI: 10.1111/j.1749-6632.2009.05312.x |
0.737 |
|
2010 |
Yadav VK, Arantes HP, Barros ER, Lazaretti-Castro M, Ducy P. Genetic analysis of Lrp5 function in osteoblast progenitors. Calcified Tissue International. 86: 382-8. PMID 20333369 DOI: 10.1007/s00223-010-9350-7 |
0.732 |
|
2010 |
Yadav VK, Balaji S, Suresh PS, Liu XS, Lu X, Li Z, Guo XE, Mann JJ, Balapure AK, Gershon MD, Medhamurthy R, Vidal M, Karsenty G, Ducy P. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nature Medicine. 16: 308-12. PMID 20139991 DOI: 10.1038/Nm.2098 |
0.744 |
|
2009 |
Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, John Mann J, Hen R, Ducy P, Karsenty G. LDL-receptor related protein five controls bone formation by inhibiting serotonin synthesis in the duodenum Obstetrical and Gynecological Survey. 64: 240-242. DOI: 10.1097/01.Ogx.0000345723.85624.24 |
0.765 |
|
2008 |
Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P, Karsenty G. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 135: 825-37. PMID 19041748 DOI: 10.1016/J.Cell.2008.09.059 |
0.768 |
|
2008 |
Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proceedings of the National Academy of Sciences of the United States of America. 105: 5266-70. PMID 18362359 DOI: 10.1073/Pnas.0711119105 |
0.76 |
|
2008 |
Takeda S, Ducy P. Regulation of Bone Remodeling by Central and Peripheral Nervous Signals Principles of Bone Biology, Two-Volume Set. 2: 1059-1068. DOI: 10.1016/B978-0-12-373884-4.00016-1 |
0.679 |
|
2007 |
Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell. 130: 456-69. PMID 17693256 DOI: 10.1016/J.Cell.2007.05.047 |
0.774 |
|
2006 |
Vaes BL, Ducy P, Sijbers AM, Hendriks JM, van Someren EP, de Jong NG, van den Heuvel ER, Olijve W, van Zoelen EJ, Dechering KJ. Microarray analysis on Runx2-deficient mouse embryos reveals novel Runx2 functions and target genes during intramembranous and endochondral bone formation. Bone. 39: 724-38. PMID 16774856 DOI: 10.1016/J.Bone.2006.04.024 |
0.54 |
|
2006 |
Karsenty G, Ducy P. The hypothalamic control of bone mass, implication for the treatment of osteoporosis. Annales D'Endocrinologie. 67: 123. PMID 16639361 DOI: 10.1016/S0003-4266(06)72566-5 |
0.387 |
|
2005 |
Ijiri K, Zerbini LF, Peng H, Correa RG, Lu B, Walsh N, Zhao Y, Taniguchi N, Huang XL, Otu H, Wang H, Wang JF, Komiya S, Ducy P, Rahman MU, et al. A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. The Journal of Biological Chemistry. 280: 38544-55. PMID 16144844 DOI: 10.1074/Jbc.M504202200 |
0.4 |
|
2003 |
Elefteriou F, Ducy P. [Control of body mass by leptin occurs through the sympathetic nervous system]. Medecine Sciences : M/S. 19: 391-3. PMID 12836204 DOI: 10.1051/Medsci/2003194391 |
0.578 |
|
2003 |
Krishnan V, Moore TL, Ma YL, Helvering LM, Frolik CA, Valasek KM, Ducy P, Geiser AG. Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling. Molecular Endocrinology (Baltimore, Md.). 17: 423-35. PMID 12554794 DOI: 10.1210/Me.2002-0225 |
0.477 |
|
2002 |
Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell. 111: 305-17. PMID 12419242 DOI: 10.1016/S0092-8674(02)01049-8 |
0.813 |
|
2002 |
Zambotti A, Makhluf H, Shen J, Ducy P. Characterization of an osteoblast-specific enhancer element in the CBFA1 gene. The Journal of Biological Chemistry. 277: 41497-506. PMID 12186862 DOI: 10.1074/Jbc.M204271200 |
0.388 |
|
2001 |
Amling M, Pogoda P, Beil FT, Schilling AF, Holzmann T, Priemel M, Blicharski D, Català -Lehnen P, Rueger JM, Ducy P, Karsenty G. Central control of bone mass: brainstorming of the skeleton. Advances in Experimental Medicine and Biology. 496: 85-94. PMID 11783628 DOI: 10.1007/978-1-4615-0651-5_9 |
0.7 |
|
2001 |
Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. The Embo Journal. 20: 2254-72. PMID 11331591 DOI: 10.1093/Emboj/20.9.2254 |
0.549 |
|
2001 |
Takeda S, Bonnamy JP, Owen MJ, Ducy P, Karsenty G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes & Development. 15: 467-81. PMID 11230154 DOI: 10.1101/Gad.845101 |
0.703 |
|
2000 |
Ducy P. CBFA1: A molecular switch in osteoblast biology Developmental Dynamics. 219: 461-471. PMID 11084646 DOI: 10.1002/1097-0177(2000)9999:9999<::Aid-Dvdy1074>3.0.Co;2-C |
0.55 |
|
2000 |
Ducy P, Schinke T, Karsenty G. The Osteoblast: A Sophisticated Fibroblast under Central Surveillance Science. 289: 1501-1504. PMID 10968779 DOI: 10.1126/Science.289.5484.1501 |
0.757 |
|
2000 |
Ducy P, Karsenty G. The family of bone morphogenetic proteins Kidney International. 57: 2207-2214. PMID 10844590 DOI: 10.1046/J.1523-1755.2000.00081.X |
0.64 |
|
2000 |
Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 100: 197-207. PMID 10660043 DOI: 10.1016/S0092-8674(00)81558-5 |
0.796 |
|
1999 |
Karsenty G, Ducy P, Starbuck M, Priemel M, Shen J, Geoffroy V, Amling M. Cbfa1 as a regulator of osteoblast differentiation and function. Bone. 25: 107-108. PMID 10423032 DOI: 10.1016/S8756-3282(99)00111-8 |
0.639 |
|
1999 |
Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes & Development. 13: 1025-36. PMID 10215629 DOI: 10.1101/Gad.13.8.1025 |
0.752 |
|
1999 |
Ducy P, Karsenty G. Transcriptional Control of Osteoblast Differentiation The Endocrinologist. 9: 32-35. DOI: 10.1097/00019616-199901000-00007 |
0.464 |
|
1998 |
Ducy P, Karsenty G. Genetic control of cell differentiation in the skeleton. Current Opinion in Cell Biology. 10: 614-619. PMID 9818172 DOI: 10.1016/S0955-0674(98)80037-9 |
0.548 |
|
1998 |
Corral DA, Amling M, Priemel M, Loyer E, Fuchs S, Ducy P, Baron R, Karsenty G. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 95: 13835-40. PMID 9811887 DOI: 10.1073/Pnas.95.23.13835 |
0.74 |
|
1998 |
Frendo JL, Xiao G, Fuchs S, Franceschi RT, Karsenty G, Ducy P. Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo. The Journal of Biological Chemistry. 273: 30509-16. PMID 9804819 DOI: 10.1074/Jbc.273.46.30509 |
0.571 |
|
1998 |
Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone. 23: 187-96. PMID 9737340 DOI: 10.1016/S8756-3282(98)00092-1 |
0.658 |
|
1997 |
Xiao G, Cui Y, Ducy P, Karsenty G, Franceschi RT. Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Molecular Endocrinology (Baltimore, Md.). 11: 1103-13. PMID 9212058 DOI: 10.1210/Mend.11.8.9955 |
0.386 |
|
1997 |
Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, Geoffroy V, Ducy P, Karsenty G. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nature Genetics. 16: 307-10. PMID 9207800 DOI: 10.1038/Ng0797-307 |
0.606 |
|
1997 |
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 89: 747-54. PMID 9182762 DOI: 10.1016/S0092-8674(00)80257-3 |
0.621 |
|
1997 |
Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 386: 78-81. PMID 9052783 DOI: 10.1038/386078A0 |
0.686 |
|
1997 |
Zhang R, Ducy P, Karsenty G. 1,25-Dihydroxyvitamin D3 Inhibits Osteocalcin Expression in Mouse through an Indirect Mechanism Journal of Biological Chemistry. 272: 110-116. PMID 8995235 DOI: 10.1074/Jbc.272.1.110 |
0.528 |
|
1996 |
Ducy P, Geoffroy V, Karsenty G. Study of Osteoblast-Specific Expression of One Mouse Osteocalcin Gene: Characterization of the Factor Binding to OSE2 Connective Tissue Research. 35: 7-14. PMID 9084638 DOI: 10.3109/03008209609029169 |
0.521 |
|
1996 |
Galéra P, Park R, Ducy P, Mattéi M, Karsenty G. c-Krox binds to several sites in the promoter of both mouse type I collagen genes. Structure/function study and developmental expression analysis. Journal of Biological Chemistry. 271: 21331-21339. PMID 8702912 DOI: 10.1074/Jbc.271.35.21331 |
0.509 |
|
1996 |
Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature. 382: 448-52. PMID 8684484 DOI: 10.1038/382448A0 |
0.685 |
|
1995 |
Geoffroy V, Ducy P, Karsenty G. A PEBP2/AML-1-related Factor Increases Osteocalcin Promoter Activity through Its Binding to an Osteoblast-specific cis-Acting Element Journal of Biological Chemistry. 270: 30973-30979. PMID 8537354 DOI: 10.1074/Jbc.270.52.30973 |
0.524 |
|
1995 |
Ducy P, Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Molecular and Cellular Biology. 15: 1858-1869. PMID 7891679 DOI: 10.1128/Mcb.15.4.1858 |
0.511 |
|
1994 |
Galéra P, Musso M, Ducy P, Karsenty G. c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proceedings of the National Academy of Sciences of the United States of America. 91: 9372-9376. PMID 7937772 DOI: 10.1073/Pnas.91.20.9372 |
0.543 |
|
1994 |
Galéra P, Desbois C, Ducy P, Karsenty G. La régulation de l'expression des gènes du collagène de type I : implication pour l'étude de la sclérodermie MéDecine/Sciences. 10: 1253. DOI: 10.4267/10608/2564 |
0.444 |
|
Show low-probability matches. |